FDA Approves Tezspire for Self-Administration With New Prefilled Pen
The new prefilled, single-use pen is provided as 210mg/1.91mL (110mg/mL) for subcutaneous injection into the thigh or abdomen.
Diagnosis & Disease Information
Fixed-Dose Combo Airsupra Approved as Rescue Therapy for Asthma
Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.
FDA Panel Votes on New Combination Therapy for Asthma
The vote was mixed when the data was reviewed for younger patients.
Omalizumab Improves Outcomes in Allergic Asthma Even With Off-Label Dosing
Can patients with allergic asthma benefit from omalizumab even if they fall outside the criteria put forth in the approved recommended dosing table?
Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma
Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.
Switching or Stopping Biologic Therapy in Severe Asthma Yields Worse Outcomes
The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.
SABA Refills More Common in Moderate/Severe Persistent Asthma
To better understand SABA usage and its implications, investigators examined prescription fulfillment patterns among patients with all levels of asthma severity.
Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers
A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.
Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers
A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.
Dupilumab May Reduce Steroid Use in Aspirin-Exacerbated Respiratory Disease
Researchers assessed the difference in oral steroid usage across 3 treatment modalities: aspirin desensitization, biologics, and endoscopic sinus surgery.
